Processa Pharmaceuticals, Inc. Income Taxes Paid
Processa Pharmaceuticals, Inc. (PCSA) reported Income Taxes Paid of $1.93 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2017-11-20
- Processa Pharmaceuticals, Inc. income taxes paid for the quarter ending 2014-03-31 was $0.00.
- Processa Pharmaceuticals, Inc. income taxes paid for the quarter ending 2013-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. income taxes paid for the quarter ending 2013-09-30 was $0.00.
- Processa Pharmaceuticals, Inc. income taxes paid for the quarter ending 2012-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. income taxes paid for fiscal 2014 was $132.00, a 32.00% increase from fiscal 2013.
- Processa Pharmaceuticals, Inc. income taxes paid for fiscal 2013 was $100.00, a 0.00% change from fiscal 2012.
- Processa Pharmaceuticals, Inc. income taxes paid for fiscal 2012 was $100.00.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month | Income Taxes Paid 27 month | Income Taxes Paid 30 month | Income Taxes Paid 33 month | Income Taxes Paid 36 month |
|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | $1.93K 10-Q · filed 2017-11-20 | |||||||
| 2014-12-31 | $132.00 10-K · filed 2017-06-19 | |||||||
| 2014-03-31 | $0.00 derived: 10-Q 36 month − 10-K 33 month · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2015-04-14 | $0.00 derived: sum of 3 quarters · filed 2015-04-14 | $200.00 10-Q · filed 2014-05-14 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $0.00 derived: sum of 2 quarters · filed 2015-04-14 | $100.00 10-K · filed 2015-04-14 | $200.00 10-K · filed 2014-03-27 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $100.00 10-Q · filed 2014-11-13 | $300.00 10-Q · filed 2013-11-08 | |||||
| 2013-06-30 | $100.00 10-Q · filed 2014-08-19 | $300.00 10-Q/A · filed 2013-09-06 | ||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $100.00 10-K · filed 2014-03-27 | ||||||
| 2012-09-30 | $100.00 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |